Prognostic markers for detection of coexistent carcinoma in high-risk endometrial hyperplasia

Anticancer Research

Volumn 30, Issue 11, 2010, Pages 4649-4655

  Orbo A ^a,b   Moe, B T ^b   Arnes, M ^a   Pettersen, I ^b   Larsen, K ^b   Eggen, T ^b   Myrmel, K ^b   Hanssen, K ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Endometrial hyperpasia; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM TUMOR; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MORPHOMETRICS; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 78650233028     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Horn LC, Schnurrbusch U, Bilek K, Hentschel B and Einenkel J: Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment. Int J Gynecol Cancer 14: 348-353, 2004.
2. Kurman RJ, Kaminski PF and Norris HJ: The behavior of endometrial hyperplasia. A long-term study of 'untreated' hyperplasia in 170 patients. Cancer 56: 403-412, 1985.
3. Baak JP, Nauta JJ, Wisse-Brekelmans EC and Bezemer PD: Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone. J Pathol 154: 335-341, 1988.
4. Kendall BS, Ronnett BM, Isacson C, Cho KR, Hedrick L, ener-West M and Kurman RJ: Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 22: 1012-1019, 1998.
5. Bergeron C, Nogales FF, Masseroli M, Abeler V, Duvillard P, Muller-Holzner E, Pickartz H and Wells M: A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol 23: 1102-1108, 1999.
6. Dietel M: The histological diagnosis of endometrial hyperplasia. Is there a need to simplify? Virchows Arch 439: 604-608, 2001.
7. Hecht JL, Ince TA, Baak JP, Baker HE, Ogden MW and Mutter GL: Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis. Mod Pathol 18: 324-330, 2005.
8. Zaino RJ, Kauderer J, Trimble CL, Silverberg SG, Curtin JP, Lim PC and Gallup DG: Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 106: 804-811, 2006.
9. Orbo A, Baak JP, Kleivan I, Lysne S, Prytz PS, Broeckaert MA, Slappendel A and Tichelaar HJ: Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern Norway. J Clin Pathol 53: 697-703, 2000.
10. Mutter GL, Baak JP, Cram CP, Richart RM, Ferenczy A and Faquin WC: Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol 190: 462-469, 2000.
11. Baak JP, Orbo A, van Diest PJ, Jiwa M, de BP, Broeckaert M, Snijders W, Boodt PJ, Fons G, Burger C, Verheijen RH, Houben PW, The HS and Kenemans P: Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias. Am J Surg Pathol 25: 930-935, 2001.
12. Baak JP, Mutter GL, Robboy S, van Diest PJ, Uyterlinde AM, Orbo A, Palazzo J, Fiane B, Lovslett K, Burger C, Voorhorst F and Verheijen RH: The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer 103: 2304-2312, 2005.
13. Baak JP, Kurver PH, Overdiep SH, Delemarre JF, Boon ME, Lindeman J and Diegenbach PC: Quantitative, microscopical, computer-aided diagnosis of endometrial hyperplasia or carcinoma in individual patients. Histopathology 5: 689-695, 1981.
14. Mutter GL, Kauderer J, Baak JP and Alberts D: Biopsy histomorphometry predicts uterine myoinvasion by endometrial carcinoma: a Gynecologic Oncology Group study. Hum Pathol 39: 866-874, 2008.
15. Orbo A, Arnes M, Hancke C, Vereide AB, Pettersen I and Larsen K: Treatment results of endometrial hyperplasia after prospective D-score classification A follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Gynecol Oncol 2008.
16. Vereide AB, Arnes M, Straume B, Maltau JM and Orbo A: Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecologic Oncology 91: 526-533, 2003.
17. Baak JP, Kurver PH, Diegenbach PC, Delemarre JF, Brekelmans EC and Nieuwlaat JE: Discrimination of hyperplasia and carcinoma of the endometrium by quantitative microscopy - a feasibility study. Histopathology 5: 61-68, 1981.
18. Baak JP, Kurver PH and Boon ME: Computer-aided application of quantitative microscopy in diagnostic pathology. Pathol Annu 17(Pt 2): 287-306, 1982.
19. Mutter GL, Zaino RJ, Baak JP, Bentley RC and Robboy SJ: Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol 26: 103-114, 2007.
20. Mutter GL: Diagnosis of premalignant endometrial disease. J Clin Pathol 55: 326-331, 2002.
21. Campbell PE and Barter RA: The significance of a typical endometrial hyperplasia. J Obstet Gynaecol Br Commonw 68: 668-672, 1961.
22. Gore H and Hertig AT: Carcinoma in situ of the endometrium. Am J Obstet Gynecol 94: 134-155, 1966.
23. Gusberg SB and Kaplan AL: Precursors of corpus cancer. IV. adenomatous hyperplasia as stage O carcinoma of the endometrium. Am J Obstet Gynecol 87: 662-678, 1963.
24. Hendrickson MR and Kempson RL: The differential diagnosis of endometrial adenocarcinoma. Some viewpoints concerning a common diagnostic problem. Pathology 12: 35-61, 1980.
25. Kurman RJ and Norris HJ: Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 49: 2547-2559, 1982.
26. Tavassoli F and Kraus FT: Endometrial lesions in uteri resected for atypical endometrial hyperplasia. Am J Clin Pathol 70: 770-779, 1978.
27. Vellios F: Endometrial hyperplasias, precursors of endometrial carcinoma. Pathol Annu 7: 201-229, 1972.
28. Longacre TA, Chung MH, Jensen DN and Hendrickson MR: Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion. Am J Surg Pathol 19: 371-406, 1995.
29. Skov BG, Broholm H, Engel U, Franzmann MB, Nielsen AL, Lauritzen AF and Skov T: Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia. Int J Gynecol Pathol 16: 33-37, 1997.
30. Dunton CJ, Baak JP, Palazzo JP, van Diest PJ, McHugh M and Widra EA: Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer. Am J Obstet Gynecol 174: 1518-1521, 1996.
31. Janicek MF and Rosenshein NB: Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia. Gynecol Oncol 52: 373-378, 1994.
32. Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, Alberts D and Curtin J: Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 106: 812-819, 2006.
33. Baak JP, Kurver PH, Overdiep SH, Delemarre JF, Boon ME, Lindeman J and Diegenbach PC: Quantitative, microscopical, computer-aided diagnosis of endometrial hyperplasia or carcinoma in individual patients. Histopathology 5: 689-695, 1981.